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Background: To address the growing problem of epilepsy among aging Veterans and younger Veterans who have
experienced a traumatic brain injury (TBI), the Veterans Health Administration (VA) has implemented 16 Epilepsy
Centers of Excellence (ECOE) to assure increased access to high quality of care for Veterans with epilepsy. Each
ECOE consists of a network of regional hubs to which spoke facilities refer Veterans for subspecialty treatment. The
ECOEs are expected to improve access to and quality of epilepsy care through patient care, consultation and
education. This study aims to: evaluate the effectiveness of the ECOE structure by describing changes in the quality
of and access to care for epilepsy before and after the ECOE initiative using QUality Indicators in Epilepsy Treatment
(QUIET Indicators); describe associations between changes in the structure and processes of care and Relational
Coordination (RC), a model of task-oriented communication that has been shown to play a role in implementation
science; and determine if variations in care are related to levels of RC.
Methods: This four-year comparative case study uses a mixed-methods approach. We will use VA inpatient,
outpatient, pharmacy, and chart abstraction data to identify changes in the quality of and access to epilepsy care in
the VA between Fiscal Year 2008 and Fiscal Year 2014. Qualitative and survey methods will be used to identify
changes in the structure and processes of epilepsy care and RC over the course of the study. We will then link data
from the first two objectives to determine the extent to which quality of and access to epilepsy care is associated
with RC using multivariable models.
Discussion: This innovative study has the potential to improve understanding of hub-and-spoke model effectiveness,
VA epilepsy care, and models of epilepsy specialty care more globally. Moreover, it contributes to implementation
science by advancing understanding of the role of RC in the context of a major transformation in the structure of
care delivery in a national integrated healthcare system.
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Epilepsy is a growing problem in the Veterans Health Ad-
ministration (VA) patient population among aging Veterans
of Vietnam and younger Veterans of Operation Enduring
Freedom/Operation Iraqi Freedom (OEF/OIF) who have
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unless otherwise stated.factor for new-onset epilepsy in younger adults. To address
this concern, the VA has implemented Epilepsy Centers of
Excellence (ECOE) to assure increased access to high qua-
lity of care for Veterans with epilepsy.
Mandated by the Veterans Mental Health and Other
Care Improvements Act of 2008 (PL110-387), the ECOE
is comprised of 16 VA ‘hub’ facilities geographically dis-
persed in four regions to which ‘spoke’ facilities that lack
specialty care and/or necessary diagnostic equipment may
refer Veterans for specialty care within their region. Hubs
within each region are linked to an accredited medicaltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Pugh et al. Implementation Science 2014, 9:44 Page 2 of 10
http://www.implementationscience.com/content/9/1/44school and a Polytrauma Rehabilitation Center (PRC),
which treats Veterans with TBI who at risk of developing
post-traumatic epilepsy (PTE). This hub and spoke net-
work is led by a national director with regional directors
overseeing hubs within each region (Figure 1). This net-
work structure was designed to improve access to epilepsy
specialty care to Veterans across the country. Ideally, ac-
cess is improved directly by providing a referral network
for Veterans from remote sites and indirectly by providing
outreach education and telehealth opportunities for pa-
tient consultation.
The ECOE’s program goals are to establish a national
system of care that functions as a center of excellence in
research, education, and clinical care activities in the
diagnosis and treatment of epilepsy. ECOE directors are
tasked with developing a national consortium of pro-
viders at spoke facilities lacking requisite resources to
ensure better access to diagnosis, research, clinical care,
and education. The ECOE also disseminates up-to-date
information on epilepsy and epilepsy care for Veterans
via written and web-based modalities. Thus, the goals of
this network are to improve access to VA epilepsyFigure 1 Epilepsy centers of excellence organizational structure.specialty care and improve the quality of care provided
to those who receive chronic disease management in pri-
mary care and general neurology settings.
Quality of care: epilepsy
The limited research on the quality of epilepsy care in
the United States suggests room for improvement both
within and outside the VA. Our prior work, among the
earliest example of epilepsy quality assessment in the
elderly [1-3] found that over half of older Veterans with
new-onset epilepsy received sub-optimal anti-epileptic
drugs (AEDs), according to recommendations on appro-
priate medications for geriatric patients [1,2]. Studies in
non-VA settings found that the time from epilepsy diag-
nosis to referral for surgery for temporal lobe epilepsy
patients who fail two or more first-line AEDs remains
relatively unchanged at 18 years [4], despite recommen-
dations for referral after only one year of AED failure by
the National Association of Epilepsy Centers [5]. Poorly
controlled epilepsy is associated with increased cognitive
dysfunction, mortality, injury and lower quality of life
[6-17], and accounts for 80% of the cost of treating
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of epilepsy care has implications for patient outcomes
and healthcare costs.
We developed the first quality measures for the care of
adults with epilepsy, the QUality Indicators for Epilepsy
Treatment (QUIET), for use in primary care and general
neurology settings using an evidence-based expert consen-
sus process (Appendix) [19]. These measures were used as
a foundation for the American Academy of Neurology
Epilepsy Quality Indicators [20]. Our work in non-VA set-
tings found that the concordance between recommended
and actual care provided ranged from 0% to 99%, with
44.2% of recommended care processes being performed.
Data indicated similar proportions of concordance for
initial seizure assessment (42%), initial epilepsy diagnosis
and treatment (44%), chronic epilepsy care (46%), and as-
pects of care unique to women (36%). More recently, we
adapted these indicators to the unique setting of the inte-
grated VA healthcare system (QUIET-VA). We do not
know whether Veterans living with epilepsy are receiving
high quality care as defined by the QUIET-VA measure,
or if access to care and quality of care have improved since
implementation of the ECOE initiative.
The role of relational coordination
In the Center of Excellence (COE) model of care deliv-
ery, access and quality are dependent upon the intercon-
nections between individuals working to facilitate care in
the hub and spoke system [21]. For example, informa-
tion must flow effectively between hub and spoke for
care to be timely, coordinated and appropriate for the
patient. Thus, access and quality are properties that
emerge from the hub and spoke system [22]. Assessing
the impact of the ECOE initiative on access and quality
requires an assessment of the interconnections and
interdependencies among the hubs and spokes [23].
The ECOE model is intended to improve coordination
among members of the epilepsy care team. For example,
greater interaction of epilepsy specialty providers in
team meetings and patient consultation may facilitate an
awareness of how their work relates to the overall goals
of the patient and to others in the epilepsy patient care
team. Educational outreach may also increase interaction
of epileptologists with primary care and general neur-
ology providers, stimulating a sense of alignment and
shared knowledge regarding their role in providing high
quality epilepsy care.
Studies over the past decade indicate that the relation-
ships, interactions, communication patterns, and flow
of information among the individuals within the health-
care team are important to its functioning [21,24-26].
Simply changing structures and processes does not always
lead to better outcomes [27,28]. Rather, changes in the
organization and delivery of care that lead to increasinginterconnections and to timely, accurate, problem-solving
communication should generate better quality of care and
patient outcomes. Relational Coordination (RC), mutually
reinforcing interactions between communication and rela-
tionships within a team for the purpose of task integration
[29], has been shown to be an important predictor of a
team’s or organization’s ability to provide high quality care
[30-33]. RC describes and measures cross-role or cross-
task shared knowledge, shared goals and mutual respect
among team members as well as the frequency, timeliness,
accuracy, and problem-solving orientation of communica-
tion among team members. Furthermore, recent work sug-
gests that team leaders play an essential role in promoting
healthy communication, relationships, and learning among
work groups that appear to be essential for coordinating
and achieving complex goals [34,35].
In a setting such as the ECOEs where goals are defined
broadly and leaders are allowed flexibility in achieving
those goals, we believe Relational Coordination will have
a significant influence on the quality of care provided.
Hypotheses and objectives
We hypothesize that ECOE implementation would be
associated with significant improvements in the quality
of epilepsy care in such areas as: a) Veterans with newly
diagnosed epilepsy, b) Veterans with chronic epilepsy, c)
referrals, and d) epilepsy surgery as evidenced by a higher
proportion of recommended processes of care delineated
in the QUIET measures being performed for Veterans
with epilepsy. Based on the RC framework, we propose
that changes in the organization and delivery of care
(e.g., broaden the membership of epilepsy care team,
use of care pathways) which promote timely, accurate,
and problem-solving communication among the epilepsy
care team will lead to higher quality and more efficient
epilepsy care.
Objective 1: Describe changes in quality of and access
to epilepsy care before and after the ECOE initiative. We
expect that the ECOE implementation will lead to sig-
nificant improvements in the quality of epilepsy care as
evidenced by a higher proportion of recommended pro-
cesses of care delineated in the QUIET measures being
performed.
Objective 2: Describe the associations between changes
in the structure/ processes of care implemented by the
four geographic ECOEs and RC among epilepsy care
team members in each ECOE region. We expect that
the ECOE regions that enact strategies that enhance RC
(e.g., video case-conferences between hub and spoke
physicians) will have higher RC scores than ECOEs that
rely on traditional referral modalities (e.g., electronic con-
sults) between facilities.
Objective 3: Determine whether variations in quality
of and access to VA epilepsy care among ECOEs are
Table 1 Outcome measures, data sources, and definitions
for Objective 1
Type of measure Data source(s) Data used to define
Quality
QUIET-VA VistA Web Medical chart progress notes,





PTF Inpatient bedsection 11
(Epilepsy center) Clinic Stop:
315456 Epilepsy clinic FY11
onward: 345 Epilepsy center
of excellence; other epilepsy















PTF Inpatient bedsection: 10
Neurology, 34 geriatric
evaluation neurology
OPC Clinic stop: 315 neurology
clinic
OPC: outpatient clinic PTF: patient treatment file; VistA Web: Veterans Health
Information Systems Technology and Architecture Web.
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We are conducting a four-year comparative case study
using a mixed-methods approach that incorporates strat-
egies from patient safety/process improvement and imple-
mentation science [27,36]. We are using VA inpatient,
outpatient, pharmacy, and chart abstraction data to iden-
tify changes in quality of and access to epilepsy care in the
VA between FY08-FY14 (Objective 1). Qualitative and
survey methods will be used to identify changes in the
structure and processes of epilepsy care and RC over the
course of the study (Objective 2). We will then link data
from the first two objectives to determine the extent to
which quality of and access to epilepsy care is associated
with RC using multivariable models (Objective 3).
Study population
Veterans meeting criteria for epilepsy using our previously
validated epilepsy identification algorithm comprise the
population for quality assessment (Objectives 1 and 3).
Briefly, individuals with a diagnosis indicative of epilepsy
(ICD-9-CM codes 345, 780.39, 649.4) who have concomi-
tant use of an AED will be included. Using algorithms and
techniques developed in previously funded VA studies, we
will classify Veterans’ epilepsy status as being New-Onset,
Chronic or New to VA [2]. We will also use administrative
databases to classify epilepsy status as poorly controlled if
they receive emergency or hospital care with a primary
diagnosis of seizure/epilepsy, use two or more AEDs,
switch AEDs, or have a designation of intractability in
the epilepsy specific diagnosis.
Using the overall VA patient epilepsy population, we will
first identify random samples of individuals from each
geographic ECOE stratified by onset (new, chronic)
and severity (controlled, poorly controlled) in FY08
(N = 1,600), FY12 (N = 1,600), and FY14 (N = 1,600) for
comparison of pre- and post-implementation of ECOE.
The QUIET-VA measure (Appendix) will be used to iden-
tify quality of VA epilepsy care through medical chart
abstraction (Additional file 1) in the year prior to ECOE
implementation (FY08) and the years post-implementation
(FY12, FY14). Secondary analyses will use population-
based administrative data to assess broad measures of ac-
cess to neurology and epilepsy specialty care to determine
if access to epilepsy specialty care improved over the study
period.
For Objective 2, we will sample individuals involved in
the care of Veterans with epilepsy in select VA facilities,
sampling each hub and spoke, and conduct an in-depth
study in each hub-spoke system.Data sources
For Objective 1, we will employ three datasets to obtain
information about inpatient/outpatient medical encoun-
ters, medication, and detailed information about care
processes (Tables 1 and 2).
Medical SAS Datasets: National administrative data
for VA-provided healthcare are stored as Medical SAS
Datasets in the VA national data repository in Austin,
TX. These data repositories are updated daily with in-
patient and outpatient encounter data from VA clinical
information systems and include patient demographic
information, date and type of care (clinic code for out-
patient or bed section for inpatient care), up to 10 diag-
noses, procedures, and provider type; inpatient files also
include length of stay. Secondary analyses will examine
access to epilepsy specialty care and epilepsy surgery.
VA Pharmacy Benefits Management (PBM) Data: We
will use the outpatient pharmacy database, which con-
tains prescription information for individual VA patients
receiving medications from the VA, to identify individ-
uals receiving AEDs (for epilepsy algorithm) and identify
specific medications that are of interest for QUIET VA
measure (e.g., warfarin, folate).
Medical chart abstraction: To examine the quality of
epilepsy care as defined by the QUIET VA measure, we
will perform medical chart abstractions for individuals
identified above (Additional file 1). Two chart abstrac-
tors will use this tool, independently reviewing 10 charts;
disagreements will be resolved by consensus. After there
is 90% agreement on abstracted items, chart abstractors
Table 2 Covariates for Objective 1 Analyses
Type of
measure









Pharmacy VA product; total number of oral,




OPC, PTF Traumatic brain injury, migraine/






OPC, PTF Substance use disorder, schizophrenia,
depression, bipolar disorder,




OPC: outpatient clinic; PTF: patient treatment file.
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ized chart abstraction form. In addition to quality, we
will identify individuals who have epilepsy surgery, ex-
tended video EEG monitoring, or other procedures out-
side the VA.
Data for Objective 2 will be derived from surveys of
epilepsy care teams from each selected facility (Table 3)
and semi-structured interviews conducted with staff at
selected facilities (Table 4). Semi-structured interviews
will ask participants to articulate changes in the care
processes. Moreover, archival documents generated by
the ECOE (e.g., annual reports, minutes) and observa-
tions of meetings conducted by various ECOE groups
(e.g., Directors, Basic Research) will be analyzed to
examine the emerging impact of changes in the ECOE
system.Table 3 Relational Coordination dimensions [29]
Dimension Survey Item
Frequent communication How frequently do you communicate with peo
Timely communication Do people in these groups communicate with y
Accurate communication Do people in these groups communicate with y
Problem-solving
Communication
When a problem occurs with epilepsy patients,
Shared goals How much do people in these groups share yo
Shared knowledge How much do people in each of these groups k
Mutual respect How much do people in these groups respect
Communication modalities Which of the following communication vehicles
primary care providers (Check all that apply): ph
video conferencing/meetings, tele-conferencing
for epilepsy, notes in the electronic medical recoMeasures
Epilepsy status: Based on our algorithm, individuals who
meet inclusion criteria for epilepsy and who have no use
of antiepileptic drugs the year prior to the initial diagno-
sis (or who receive a new AED after the initial seizure)
will be classified as having New-Onset epilepsy. Individ-
uals with prior evidence of epilepsy will be classified as
having Chronic epilepsy. Veterans without prior data will
be classified as New to VA. The epilepsy severity described
above will be used to identify individuals in the database
who are more likely to have poorly controlled epilepsy
(i.e., individuals who receive emergency or hospital care
with a primary diagnosis of epilepsy and/or individuals re-
ceiving two or more AEDs after new diagnosis).
Quality of epilepsy care: We will first identify the com-
pletion of recommended care based on the QUIET-VA
measure (Additional file 1) for each individual. Quality
of epilepsy care will be quantified as the proportion of
recommended processes of care that were provided for
each patient. We will examine overall quality, using the
same categories used in our prior study: new seizure, ini-
tial diagnosis and treatment, chronic epilepsy care, and
care unique to women.
Access to VA neurology and epilepsy care: Secondary
analyses will also examine access to epilepsy specialty
care and neurology care first using National VA admin-
istrative data. The primary measure, Epilepsy Specialty
Care, will identify individuals who receive any inpatient
or outpatient Epilepsy Specialty care based on clinic
codes, ICD-9A and CPT codes.
Patient characteristics: In addition to our primary
outcomes, we will identify patient characteristics for use
as covariates/case-mix adjustments for multivariable
models, and distance from the hub/spoke as a covariate
(Table 2).
Relational Coordination: The RC survey includes ques-
tions that examine seven dimensions (Table 3) of how indi-
viduals interrelate (Objective 2) [29]. We will also includeple in each of these groups about epilepsy patients?
ou in a timely way about epilepsy patients?
ou accurately about epilepsy patients?
do the people in these groups work with you to solve the problem?
ur goals regarding epilepsy patients?
now about the work you do with epilepsy patients?
the work you do with epilepsy patients?
do you use when sharing information about epilepsy patients with the
one, fax, email, text messaging, instant messaging, face-to-face meetings,
/meetings (audio), formal meetings, informal meetings, electronic consult
rds.
Table 4 Areas of exploration for key informant interviews
Area of exploration Specific information sought Sample questions
Type of epilepsy care Type of epilepsy care provided by the facility What changes to the type of care you provide have you noticed
since ECOE initiative?
Organization of care Clinical work flow at the site, e.g., in the
epilepsy clinic, neurology clinic (for Spoke
facilities without epileptologist), or ECOE
What is the structure of the epilepsy care team? How has that
changed since ECOE initiative? How have the roles of individuals
on the epilepsy care team changed since ECOE initiative?
Referral Formal policies Describe any formal changes that have been implemented since
the ECOE initiative, including clinical pathways.
Clinical work flow and communication
involved in referrals
How are Spoke-to-Hub Referrals handled? Who initiates communication
from the spoke? Who receives communication at the Hub?
How are Hub to Hub Referrals handled?
Satisfaction with referral processes How satisfied are you with the current referral processes and why?
Use of technology How is information technology (IT) being used to
manage clinical work flow?
Describe strategies that have been developed to enhance access
to epilepsy specialty care.
Describe strategies that have been developed to improve the quality
of epilepsy care for Veterans.
Do you have plans to incorporate new IT tools/ modify existing tools
to manage clinical work flow/ referral?
Educational approach Types of education being offered at the ECOE Describe the educational mission with regard to teaching fellows.
Describe approach for educational outreach.
General impact of ECOE
initiative
Most salient changes from the perspective
of clinicians/administrators
Describe the most important changes that have resulted from the
ECOE care structure.
Barriers/facilitators Describe any barriers you have encountered.
Other unexpected changes Describe any other unexpected changes or consequences you have
experienced.
Other changes Other changes in the field unrelated to
the ECOE initiative
Describe any changes in the field of epilepsy care that you believe
may have an influence on the quality of epilepsy care or access to
epilepsy care within or outside the VA.
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to face communication, email; Computerized Patient
Record System [CPRS]) within the RC survey. Items are
rated by participants on a 5-point scale indicating the
frequency to which each dimension exists in their care
setting (e.g., frequency: 1 = Never, 5 = Constantly) [29].
RC scores are first calculated for each individual by
summing the scores of all roles (e.g., neurologist, epilep-
tologist, registered nurse, etc.) for each dimension (e.g.,
frequent communication) and then dividing by the num-
ber of responses. The overall RC score for each partici-
pant is derived by calculating the mean of the seven
individual scores (range 1–5) [29].
RC scores at the facility level are calculated for each
functional group (e.g., neurologist, epileptologist, nurse
practitioner) by calculating the mean of each dimension
for all members of the functional group, and then a facil-
ity RC mean and an overall ECOE RC (hub and spokes)
mean. The primary analyses will use the regional ECOE
RC mean score, and secondary analyses will examine
variation in RC scores among functional groups and
hubs vs. spokes [29].
Semi-structured interviews: Semi-structured interviews
will be used to obtain richer details regarding theorganization of care and specific innovative approaches
used by epilepsy care teams in each ECOE to improve
the quality of and access to care (Table 4). We will use
data collected for the previous objectives to complete
Objective 3 using a mixed methods approach for study-
ing the ECOE initiative’s impact on access to and quality
of epilepsy care. Each data type will first be analyzed in-
dependently to detect key patterns and associations
among the variables in both the qualitative and quantita-
tive data. Quantitative data will be analyzed using statis-
tical methods to better understand the impact of the
ECOE initiative on access and quality. Qualitative data
will be analyzed using constant comparative analysis and
open coding methods to generate new understandings of
how the contextual nuances in the hubs and spoke facil-
ities during and after the ECOE implementation are asso-
ciated with access and quality.
Once we have generated the key findings from each data
type, we will turn our attention to integrating the findings
from these diverse data using a triangulation protocol
[37]. We define triangulation as a process of studying a
phenomenon using different methods to gain a more
complete picture. The goal of this integration is to gener-
ate knowledge that goes beyond what is suggested from
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data [38]. To do this, we will list the findings from each
data analysis effort together and consider where the
findings from each method agree, where they provide
complementary insights on the same topic, or where
they contradict each other, developing meta-themes that
go beyond simply reporting the findings from the admin-
istrative data, surveys and interviews. Final interpretations
that result from this process will arise from the patterns in
the data itself as well as the application of our primary
theoretical framework, Relational Coordination.
Study status
Recruitment for survey participation began on March 7,
2013. Survey data was collected from March 7, 2013,
and concluded April 30, 2013. Round 1 interviews com-
menced March 5, 2013, and are ongoing through March
5, 2014. Round 2 data collection is slated to be con-
ducted from September, 2014 through August, 2015.
Discussion
Despite the increasing use of COE models within the
VA, research examining this model’s effectiveness in
terms of its impact on patient outcomes is sparse. This
innovative study has the potential to improve under-
standing of hub-and-spoke model efficacy, VA epilepsy
care, and models of epilepsy specialty care more globally.
Moreover, it contributes to implementation science by
advancing understanding of the role of RC in the con-
text of a major transformation in the structure of care
delivery in a national integrated healthcare system.
Even though our project is focused on epilepsy
care, COE models are commonly used to provide
care for individuals with disease states that are less com-
mon (e.g., hepatitis C, multiple sclerosis, Parkinson’s
disease, spinal cord injury, polytrauma, etc.). Moreover,
the vast majority of specialty care within the VA is pyramid
referral-based, similar to epilepsy’s. Therefore, our findings
will be relevant to VA care delivery more generally and
may inform future decisions about the organization of VA
care for other chronic conditions.
This project will provide information regarding pos-
sible targets for future interventions, including possible
approaches based on the RC framework. Findings will
provide VA clinicians with an assessment of the quality
of VA epilepsy care and suggest areas for further im-
provement. Moreover, findings will provide VA clinicans
and researchers with information about the types of
strategies that were used in the ECOE initiative, how RC
was associated with those strategies, and which ap-
proaches were associated with improvements and which
were not. Thus, this study will provide a foundation for
the design and implementation of interventions to fur-
ther improve VA epilepsy care. Findings from this studywill also provide information to assist VA policy makers
in projecting numbers of patients with epilepsy and
adapting staffing levels to accommodate treatment for
those individuals.
We believe that findings from this study will also be
relevant in non-VA settings. The ongoing study by the
Institute of Medicine on the public health dimensions of
the epilepsies (access, quality and education) supports
concern regarding quality of and access to care broadly
in the United States [39]. To date, there has been only
one comprehensive assessment of the quality of epilepsy
care in the US. That study, conducted by our team, was
of a single healthcare system in one city, and suggested
that there is much room for improvement [19]. The pro-
posed study will provide the impetus to begin quality as-
sessment for epilepsy care by examining quality in a
national integrated healthcare system, putting the VA once
again at the forefront of epilepsy care research.
Finally, our findings may have broad implications for
healthcare delivery and system redesign. The methods of
the proposed research are rooted in the evolving sci-
ences of patient safety and process improvement and
implementation science. In the era of national healthcare
reform, these fields are increasingly important to im-
proving patient outcomes and reducing unnecessary
harm and utilization. Implications from this study may
also inform the literature these fields [21,36].Strengths
Our study applies state-of-the-art quantitative and quali-
tative approaches to a topic of high interest inside and
outside the VA. It is the first of its kind to measure the
quality of epilepsy care in a national integrated health-
care system at three points in time, while concomitantly
collecting data to describe the specific changes in struc-
ture and processes of epilepsy care in the VA that result
from the ECOE initiative. The inclusion of the RC meas-
ure further strengthens the usefulness of this study by
also contributing to implementation science and allow-
ing us to learn what works. Our methods are rigorous.
We not only triangulate data sources by using national
databases and interview data from both clinicians and
administrators, but also feedback our observations to in-
dividuals from whom the data is collected to maximize
the validity of our analysis.
While cause and effect cannot be ascertained in this
quasi-experimental study, we will have longitudinal mea-
sures that can be examined, in light of other changes in
the field, to better rule out a cohort effect. As such, our
study will provide evidence that can inform development
of interventions and subsequent research to implement
those interventions to improve quality and access to epi-
lepsy care.
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Although these data will provide important insights into
VA care processes, the findings from this integrated
healthcare system may not be generalizable to other set-
tings. These findings can, however, be used to develop
future research in other settings and further our under-
standing of relational coordination in healthcare systems
of national scope.
Conclusions
This innovative study will provide insight into the effective-
ness of the ECOE hub-and-spoke model and explore the
impact of restructuring epilepsy on VA care processes for
Veterans with epilepsy. Moreover, the study will elucidate
the role relational coordination plays in implementation
of innovations designed to improve access to and quality
of care.
Ethical considerations
This study has been approved by VA IRB Central (study
number IIR 11–067).
Appendix
QUality Indicators in Epilepsy Treatment (QUIET)
Evaluation of Initial Seizure
1. All patients should have the results of at least one
electroencephalography (EEG) reviewed or requested.
If EEG was not performed previously, then an EEG
should be performed.
2. All patients should have results of at least one
magnetic resonance imaging (MRI) or computerized
tomography (CT) scan reviewed or requested. Or, if a
MRI or CT scan was not obtained previously, then a
MRI or CT scan should be ordered (MRI preferred).
3. All patients should receive information on driving
restrictions, safety, and injury prevention.
Initial Diagnosis & Treatment
4. If a patient is thought to have a diagnosis of epilepsy,
then the diagnosis should include a best estimation
of seizure types.
5. If the patient meets the criteria for epilepsy diagnosis
(generally two unprovoked seizures), then seizure
medication (SM) treatment should be discussed with
and offered to the patient and caregivers.
6. If the patient is diagnosed with a seizure
disorder/epilepsy and started on therapy, then
monotherapy is preferred.
7. If the patient is a woman of childbearing potential
(12-44 years old), then referral to a neurologist or
an epilepsy specialist is indicated.8. If a woman with epilepsy is of childbearing
potential (12-44 years old), then she should receive
information about the teratogenicity associated with
treatment with valproate or topiramate and accept
those risks prior to treatment.
9. If the patient is diagnosed with a seizure
disorder/epilepsy, then during the visit the patient
should receive information on:
 Driving restrictions, safety and injury prevention,
diagnosis and treatment options including the
importance of taking SMs as directed
 Triggers and other lifestyle factors that may
affect seizure control (e.g. sleep deprivation,
alcohol/drug use), and contraception and family
planning
10. If a person with epilepsy is prescribed an SM that
interacts with warfarin, then INR should be
monitored within a week of any change in SM
therapy, especially during polytherapy. Once the
INR is stable, it should be monitored every four
weeks.
Chronic Epilepsy Care
11.When a patient with epilepsy receives follow-up
care, then an estimate of the number and types of
seizures since the last visit and an assessment of
drug side-effects should be documented.
12.When a patient with epilepsy receives follow-up
care, then drug side-effects should be assessed and
documented.
13. If the patient continues to have seizures after
initiating treatment, then interventions should be
performed. Options include:
 Compliance assessment/enhancement
 Monitor SM blood levels
 Increased SM dose
 Change SM dose
 Patient education regarding lifestyle modification
 Referral to higher level of epilepsy care
14. If a patient with epilepsy continues to have seizures
after three months of care by a primary care provider,
then further assessment by a neurologist should be
conducted.
15. If a patient continues to have seizures after 12
months of appropriate care by a general neurologist,
then the patient should receive a referral to an
epilepsy specialist.
16. Patients with epilepsy should receive an annual
review of information including topics such as:
 Chronic effects of epilepsy and its treatment
including
 Drug side-effects, drug-drug interactions, and
their effect on bone health,
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pregnancy or menopause may affect seizures,
 Screening for mood disorders,
 Triggers and lifestyle issues that may affect
seizures,
 Impact of epilepsy on other chronic and acute
diseases,
 Safety issues (injury prevention, burns, driving
restrictions, etc.)
 Other patient self-management issues
17. If the patient is on SM for 2 or more years, then
providers should assess bone health.
18. Individuals receiving seizure medications should be
screened for depression/suicide related behaviors
(e.g., PHQ-9) initially, then 4-6 weeks (or the next
clinic visit) after SM initiation and then at least
yearly.
19. If a person with epilepsy is found to have evidence of
a mood disorder (e.g., depression, anxiety), then
s/he should receive treatment or a referral for
mental health care.
Chronic Epilepsy Care for Women
20. If a woman with epilepsy is of childbearing
potential (12-44 years old), then she should receive
daily supplemental folate at a dose of at least 400
mcg.
21. If a woman with epilepsy is of childbearing
potential (12-44 years old) and receives oral
contraceptives in conjunction with an enzyme
inducing SM, then decreased effectiveness of oral
contraception should be addressed. (Higher doses
of oral contraceptives, alternative birth control
methods, or change SM may be needed).
22. Prenatal care for a woman with epilepsy should be
co-managed by a neurologist and an obstetrician
with experience in high risk pregnancy to assure
that issues related to the impact of epilepsy and its
treatment on the pregnancy are addressed.
Patient Generated Quality Indicator Statements
23. Providers should refer patients to local support
groups or other resources to obtain psychosocial
support.
24. Providers should encourage patients to become
educated about epilepsy and to advocate for themselves
in the health care system and with providers. For
example, provide patients with written material
about epilepsy, references to epilepsy foundation or
epilepsy web sites.
25. Providers should communicate with patients
about potential medication side effects, includingcognitive, emotional, physical and sexual side
effects.
26. Providers should give referrals to social services to
assist with employment, negotiating through the
Social Security Disability Insurance, insurance and
alternative transportation for patients who cannot
drive.
27. Providers should discuss the complexity of epilepsy
treatment and explain that each patient responds
to medications differently and that they may need
to try several different medications before they find
out what works best for that individual.
Additional file
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